Aptinyx Inc reported $10.2M in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.58B 70M
Acorda Therapeutics ACOR:US USD 19M 12M
Biogen BIIB:US USD 39.88B 774M
Cara Therapeutics CARA:US USD 577M 74M
Daiichi Sankyo 4568:JP JPY 8.16T 286.78B
Eli Lilly And LLY:US USD 347.61B 40.37B
Halozyme Therapeutics HALO:US USD 7.69B 2.25B
Intra Cellular Therapies ITCI:US USD 5.01B 605M
Marinus Pharmaceuticals MRNS:US USD 198M 49M
Neurocrine Biosciences NBIX:US USD 11.48B 1.32B
Novartis NOVN:VX USD 200.93B 19.37B
UCB UCB:BB EUR 15.68B 3.83B
Ultragenyx Pharmaceutical RARE:US USD 3.25B 348M
Vertex Pharmaceuticals VRTX:US USD 74.13B 169M